Altamira Therapeutics Ltd. Expense From Share-based Payment Transactions With Employees
Altamira Therapeutics Ltd. (CYTOF) reported Expense From Share-based Payment Transactions With Employees of $261.47 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees · last filed 2025-08-29
CHF
| Period end | Expense From Share-based Payment Transactions With Employees 6 month | Expense From Share-based Payment Transactions With Employees 12 month | Expense From Share-based Payment Transactions With Employees 12 month as first filed |
|---|---|---|---|
| 2023-12-31 | 379.41K CHF 20-F/A · filed 2024-04-22 | ||
| 2022-12-31 | 342.80K CHF 20-F/A · filed 2024-04-22 | 346.04K CHF 20-F · filed 2023-05-16 | |
| 2021-12-31 | 1.21M CHF 20-F/A · filed 2024-04-22 | ||
| 2020-12-31 | 368.79K CHF 20-F · filed 2023-05-16 | ||
| 2019-12-31 | 228.92K CHF 20-F · filed 2022-04-12 | 226.60K CHF 20-F · filed 2020-04-16 | |
| 2019-06-30 | 310.50K CHF 6-K · filed 2019-08-15 | ||
| 2018-12-31 | 42.76K CHF 20-F · filed 2021-03-31 | 27.73K CHF 20-F · filed 2019-03-14 | |
| 2017-12-31 | 354.85K CHF 20-F · filed 2020-04-16 | ||
| 2016-12-31 | 290.78K CHF 20-F · filed 2019-03-14 | ||
| 2015-12-31 | 311.67K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Expense From Share-based Payment Transactions With Employees 6 month | Expense From Share-based Payment Transactions With Employees 12 month |
|---|---|---|
| 2025-06-30 | $261.47K 6-K · filed 2025-08-29 | |
| 2024-12-31 | $532.08K 20-F · filed 2025-04-30 | |
| 2024-06-30 | $254.29K 6-K · filed 2025-08-29 | |
| 2023-12-31 | $422.27K 20-F · filed 2025-04-30 | |
| 2022-12-31 | $358.95K 20-F · filed 2025-04-30 |